Danaher Corp

NYSE: DHR
$165.95
+$2.53 (+1.5%)
Closing price February 14, 2020

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Friday's 600-point sell-off in the Dow Jones industrials actually knocked out the 2020 gains, but just two weeks ago the market was at all-time highs. China's stock market is back ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More

Stocks hit new all-time highs before recent days brought weakness around the coronavirus, which has now escalated into an international health emergency (WHO declaration). Stocks managed to recoup most of ...
Read Full Story »

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week. In fact, brokerage firm Janney spent last week visiting ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, American Power, Apache, Boeing, Ciena, Cisco, FireEye, Palo Alto, Southwest, Yum Brands and More

The futures traded higher Wednesday morning and bounced way off the overnight lows, as Wall Street continues to watch with concern the growing tension in the Middle East after Iranian ...
Read Full Story »

How Wall Street Views General Electric Ahead of Earnings

General Electric Co. (NYSE: GE) has seen so much turmoil that many investors simply don't know what to think of the company or how to evaluate it. With earnings still ...
Read Full Story »

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28, 2019, was a volatile one due to headlines about climate change discussions, the ongoing trade war with China and a potential presidential impeachment. It happened ...
Read Full Story »

Tens of Billions in New Corporate Debt Offerings at Astonishingly Low Rates

It's almost as if something funny is happening in the global bond markets. Sadly, it's not laughable funny. The trend of negative bond yields in Europe and Japan has moved ...
Read Full Story »

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Investing in the life sciences tool sector can be tricky, but according to the financial services firm Janney, the investing gain will be a result of finding the right secular ...
Read Full Story »

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

If there is one former Dow Jones industrial average leader that is in need of serious help, look no further than General Electric Co. (NYSE: GE). A new CEO has ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Caterpillar, CenturyLink, Danaher, Dillard’s, Intel, Intelsat, Mattel, ONEOK, PG&E, Windstream and More

Stocks were indicated to open lower by about 100 points on the Dow Jones industrial average and almost 10 points lower on the S&P 500 on Tuesday. What matters now ...
Read Full Story »

M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale

Investors and speculators just love a good merger and acquisition story. The story of General Electric Co. (NYSE: GE) selling its Life Sciences biotechnology instrument division to Danaher Corp. (NYSE: ...
Read Full Story »

Monday’s Biggest Winners and Losers in the S&P 500

February 25, 2019: The S&P 500 closed flat at 2,796.11. The DJIA closed up 0.2% at 26,092.22. Separately, the Nasdaq closed up 0.4% at 7,554.46. Monday was a positive day ...
Read Full Story »

What Danaher Gets by Paying $21.4 Billion for GE Biopharma Business

Medical equipment and diagnostics firm Danaher Corp. (NYSE: DHR) announced Monday morning that it has agreed to pay $21.4 billion in cash for the biopharma business of the Life Sciences' ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% ...
Read Full Story »

Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference

With the official start of summer just a few short weeks away, so is the Wall Street annual conference schedule, as the warm summer days and nights are much more ...
Read Full Story »